XBKK
THG
Market cap210mUSD
Nov 12, Last price
7.85THB
Name
Thonburi Healthcare Group PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Thonburi Healthcare Group Public Company Limited, alongside its affiliated entities, manages private hospitals throughout Thailand. The company's operations are divided into three primary segments: Medical Services, Healthcare Solution Provision, and Other Businesses. It offers a comprehensive range of medical treatments, encompassing specialized care in neurosciences, orthopedics, gastroenterology, cardiology, and obstetrics and gynecology. Additionally, the group provides management expertise for provincial government hospitals and heart centers across both public and private sectors. Its varied business interests also include offering elder care and senior living facilities, in-home healthcare services, and operating patient rehabilitation centers. Furthermore, the company engages in real estate development for senior housing, oversees elderly care facilities, and distributes a wide array of dental supply brands such as Adec, W&H, AO, Heraeus, Ivoclar, Megagen, SAM, Melag, and Alpro. Other ventures involve the retail sale of pharmaceuticals and medical supplies in specialized outlets, the creation of hospital management software, and broader property development. Thonburi Healthcare Group operates a network of hospitals that includes four facilities in or near Bangkok (Thonburi, Thonburi 2, Thonburi Bamrungmuang, and Thonburi Burana Hospital in Pathum Thani), four provincial hospitals (Rajyindee, Ubonrak Thonburi, Sirivej Chanthaburi, and Thonburi Thungsong), and one international hospital located in the Republic of the Union of Myanmar. Founded in 1976, the company maintains its headquarters in Bangkok, Thailand.
Key people
Non-Executive Chairman of the Board · since 2024
Paiboon Eksaengsri
Chief Executive Officer, Chairman of the Executive Committee, Executive Director · since 2024
Tanatip Suppradit
Executive Vice Chairman of the Board, Member of the Executive Committee, Deputy Group Chief Executive Officer and Chief Hospital Group 1 · since 2024
Wareerut Yomjinda
Vice Chairman of Executive Committee · since 2022
Pumipat Chatnoraset
Chief Financial Officer, Member of the Executive Committee · since 2024
Yothika Sripongphankul
Interim Chief Financial Officer · since 2026
Hathaichanok Pangnoi
Head of Internal Audit · since 2021
Chalermkul Apibunyopas
Executive Director, Member of the Executive Committee, Chief Executive Office Thonburi Thawiwatthana Hospital and Chief Hospital Group 2 · since 2024
Ravadee Paikoh
Acting Chief Operating Officer, Acting Chief Corporate Officer, Member of Executive Committee · since 2024
Natharak Saenchum
Member of the Executive Committee, Director of Accounting - Accounting-supervising person · since 2024
Vachiraboon Sastararuji
Member of Executive Committee · since 2020
Visit Vamvanij
Member of the Executive Committee, Chief Executive Officer Thonburi Hospital · since 2024
Charuvarn Vanasin
Director · since 2024
Rukkagee Kanchanapitak
Member of the Executive Committee, Non-Executive Director · since 2024
Sita Meksawan
Non-Executive Director · since 2015
Kajorn Thanapase
Non-Executive Director · since 2015
Aasis Unnanuntana
Non-Executive Director · since 2019
Nalin Vanasin
Non-Executive Director · since 2025
Vikrom Koompirochana
Independent Director · since 2016
Paradorn Leosakul
Independent Director · since 2025
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||